Aleksandar Sekulic, M.D., Ph.D., named deputy director, Mayo Clinic Cancer Center in Arizona
Aleksandar Sekulic, M.D., Ph.D. (IMM ’99, DERM ’00, I-1 ’01, CI ’03, DERM ’06), has been named deputy director for the Mayo Clinic Cancer Center in Arizona. He will oversee NCI-designated Comprehensive Cancer Center activities at Mayo Clinic’s campus in Arizona and will be responsible for overall strategic planning and management in Arizona.
Dr. Sekulic is an associate professor in the Department of Dermatology. His research bridges several clinical and translational disciplines in the area of cutaneous oncology. He has two National Institutes of Health Research Program Project (R01) grants and is a principal on the Stand Up to Cancer Melanoma Dream Team project, Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer.
Dr. Sekulic was principal investigator on the ERIVANCE trial, which led to the approval of vismodegib, the first hedgehog pathway inhibitor for treatment of basal cell carcinoma.
He also is associate director for the Mayo Clinic Center for Individualized Medicine and vice chair of the Department of Dermatology.
Dr. Sekulic succeeds Ruben Mesa, M.D. (MED ’95, I ’98, HEMO ’02), who has left Mayo Clinic for another opportunity.